CI Investments Inc
NBIX icon

CI Investments Inc’s Neurocrine Biosciences NBIX Stock Holding History

CI Investments Inc’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$341K Sell
2,587
-148
-5% -$19.6K ﹤0.01% 535
2025
Q4 		$388K Sell
2,735
-61
-2% -$8.84K ﹤0.01% 535
2025
Q3 		$393K Sell
2,796
-260
-9% -$35.2K ﹤0.01% 559
2025
Q2 		$384K Sell
3,056
-886
-22% -$102K ﹤0.01% 576
2025
Q1 		$436K Sell
3,942
-342
-8% -$43.3K ﹤0.01% 545
2024
Q4 		$585K Buy
4,284
+738
+21% +$91.3K ﹤0.01% 491
2024
Q3 		$409K Buy
3,546
+879
+33% +$121K ﹤0.01% 523
2024
Q2 		$367K Buy
2,667
+29
+1% +$3.98K ﹤0.01% 523
2024
Q1 		$364K Buy
2,638
+1,174
+80% +$160K ﹤0.01% 541
2023
Q4 		$193K Sell
1,464
-270
-16% -$31.1K ﹤0.01% 658
2023
Q3 		$195K Sell
1,734
-244
-12% -$25.7K ﹤0.01% 637
2023
Q2 		$187K Buy
1,978
+1,140
+136% +$111K ﹤0.01% 645
2023
Q1 		$85K Buy
838
+697
+494% +$72.5K ﹤0.01% 776
2022
Q4 		$17K Hold
141
– – ﹤0.01% 1094
2022
Q3 		$15K Sell
141
-1
-0.7% -$101 ﹤0.01% 1080
2022
Q2 		$14K Sell
142
-332
-70% -$30.6K ﹤0.01% 1013
2022
Q1 		$44K Sell
474
-28
-6% -$2.37K ﹤0.01% 974
2021
Q4 		$43K Buy
502
+94
+23% +$8.65K ﹤0.01% 1021
2021
Q3 		$39K Buy
+408
New +$38.5K ﹤0.01% 1001
2020
Q3 		– Sell
-3,565
Closed -$435K – 955
2020
Q2 		$435K Buy
+3,565
New +$394K ﹤0.01% 424

Other funds holding NBIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CI Investments Inc's NBIX Position: Q1 2026 in Review

CI Investments Inc reduced its Neurocrine Biosciences (NBIX) stake by 5.4% in Q1 2026, selling an estimated $19.6K and leaving 2,587 shares worth $341K. The position accounts for ﹤0.01% of the portfolio, ranked #535.

CI Investments Inc first reported a position in NBIX in Q2 2020 and has held it in 20 quarters since. The position peaked at $585K in Q4 2024. 696 funds tracked by Wall St. Rank hold NBIX as of Q1 2026.

  • CI Investments Inc held 2,587 shares of Neurocrine Biosciences worth $341K as of Q1 2026.
  • CI Investments Inc sold 148 Neurocrine Biosciences shares in Q1 2026, an estimated $19.6K.
  • Neurocrine Biosciences made up ﹤0.01% of CI Investments Inc's portfolio in Q1 2026, its #535 holding.
  • CI Investments Inc first reported a position in Neurocrine Biosciences in Q2 2020 and has held it in 20 quarters since.
  • CI Investments Inc's Neurocrine Biosciences position peaked at $585K in Q4 2024.
  • 696 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q1 2026.

Based on CI Investments Inc's 13F filing for Q1 2026, filed 13 May 2026.